Training and ‘sea turtles’ support WuXi Biologics’ growing China footprint
WuXi Biologics talks Chinese talent recruitment as it begins building an eighth biomanufacturing facility in the country, this one with 48,000 L of single-use bioreactor capacity. The latest addition to contract development and manufacturing organization (CDMO) WuXi Biologics’ bioproduction net ...
Regenxbio will construct a GMP facility in Maryland to produce adeno-associated viral vectors for its gene therapy programs using its NAV technol ...
Single-use adoption has gone from niche applications to standard practice in biomanufacturing says Thermo Fisher, which is expanding its disposab ...
WuXi Biologics has formed a vaccine production division to service a $3 billion strategic partnership with an unnamed global pharma.
WuXi Vacc ...
German services firm Evotec has jumped into the biologics development space through the acquisition of Just.Bio, a platform company working to re ...
Recent Tweets
-
RT @Dan5tanton: Merck KGaA reports a 15% year-on-year growth in its Process Solutions business and looks to its next-generation bio… https://t.co/kCvmcE4r1v
5 hours ago
-
German services firm @Evotec has jumped into the biologics development space through the $90m acquisition of JustBi… https://t.co/sX39nphKKF
1 day ago
-
Training and ‘sea turtles’ support WuXi Biologics China footprint https://t.co/uAPe8rTlho https://t.co/PoHnHZOlJE
2 days ago
-
RT @Dan5tanton: Bioprocessing vendor @Repligen will add eight manufacturing suites to keep ahead of demand for its large-scale OPUS… https://t.co/XcBNUmo0kB
2 days ago
Trending
Downstream Processing
eBook: Making Filtration Work
Upstream Processing
Cell Culture Bioprocessing in Perfusion: Assessing Cell Retention Technologies
Cell Line Development
Improving CHO Cells for Biomanufacturing
Ask the Experts
Automating Workflow Solutions, Not Instruments: Engineering Validated Processes for Biologics Screening